ASX News
Breaking barriers in cancer treatment: Race Oncology pioneers a new era with bisantrene
Race Oncology (ASX:RAC) has announced positive results in killing cancer cells in combination with the drug bisantrene
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| ORT | droy.... | 30/05/11 | 0 | 453 | |||
|
|||||||
| ORT | Ann: Initial Director's Interest Notice | 14/05/10 | 0 | 562 | |||
|
|||||||
| ORT | Ann: Appointment of Director | 14/05/10 | 0 | 450 | |||
|
|||||||
| ORT | Ann: Appendix 4C - monthly | 12/05/10 | 0 | 397 | |||
|
|||||||
| ORT | Ann: Timetable for Share Consolidation | 28/04/10 | 0 | 489 | |||
|
|||||||
| ORT | Ann: Results of Meeting | 23/04/10 | 0 | 451 | |||
|
|||||||
| ORT | Ann: Appendix 3B | 22/04/10 | 0 | 336 | |||
|
|||||||
| ORT | Ann: Appendix 4C - quarterly | 14/04/10 | 0 | 377 | |||
|
|||||||
See All Discussions
